Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00611182 · ClinicalTrials.gov registry record
Dyspnea in Patients With Pulmonary Fibrosis
A clinical trial, sponsored by University of California, San Francisco.
- Completed
- Registry status
- 60
- Enrollment target
NCT00611182: Completed study, sponsored by University of California, San Francisco.
NCT00611182 is a clinical trial that has completed, run by University of California, San Francisco. The registered enrollment target is 60 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00611182 has completed, sponsored by University of California, San Francisco.
- COMPLETED
- Registry status
- 60 participants
- Enrollment target
Study Summary
This study has two aims: 1. To determine the relationship of shortness of breath (dyspnea) to other conditions present in patients with pulmonary fibrosis. 2. To define the relationship between shortness of breath and rate of functional decline in patients with pulmonary fibrosis.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 60 participants |
| Start Date | 2008-01 |
| Est. Completion | 2010-03 |
What the finished NCT00611182 record still lists
NCT00611182 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 60 participants, a relatively small participant target.
The record links to 0 conditions, and to 0 interventions.
NCT00611182 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00611182 about?
NCT00611182 is a clinical study titled "Dyspnea in Patients With Pulmonary Fibrosis". This study has two aims: 1. To determine the relationship of shortness of breath (dyspnea) to other conditions present in patients with pulmonary fibrosis. 2. To define the relationship between shortness of breath and rate of functional decline in patients with pulmonary fibrosis.
What is the current status of trial NCT00611182?
This trial is currently completed. The enrollment target is 60 participants. The study started on 2008-01. Estimated completion is 2010-03.
Who is sponsoring clinical trial NCT00611182?
This trial is sponsored by University of California, San Francisco, which has 1,713 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00576069 · 60 participants
Mechanism(s)of Airflow Limitation in Moderate-severe Persistent Asthma
- NCT01297400 · 60 participants · Phase 2
Phase 2 Pilot Study of the Safety and Efficacy of Topical MW-III in Thermal Burns
- NCT01734122 · 60 participants
Stereotactic Radiosurgery for Essential Tremor and Parkinsonian Tremor
- NCT01804634 · 60 participants · Phase 2
Reduced Intensity Haploidentical BMT for High Risk Solid Tumors
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia